Status:
COMPLETED
Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalachia
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cervical Carcinoma
Human Papillomavirus Infection
Eligibility:
FEMALE
30-64 years
Phase:
NA
Brief Summary
This trial studies how well a multilevel human papillomavirus (HPV) self-testing intervention works in increasing cervical cancer screening among women in Appalachia. Most cases of cervical cancer occ...
Detailed Description
PRIMARY OBJECTIVES: Determine the effectiveness of the intervention in increasing cervical cancer screening. OUTLINE: Participants are randomized to 1 of 2 groups. GROUP I: Participants receive the...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Not within recommended cervical cancer screening guidelines for women in this age range (i.e., no Papanicolaou \[Pap\] test in last 3 years or no Pap test plus clinic-based HPV test in last 5 years)
- Resident of an Appalachian county
- Not currently pregnant
- Intact cervix
- No history of invasive cervical cancer
- Seen in a participating clinic/health system in last 2 years (i.e., active patient)
- Have a working telephone
Exclusion
Key Trial Info
Start Date :
August 27 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 11 2024
Estimated Enrollment :
802 Patients enrolled
Trial Details
Trial ID
NCT04411849
Start Date
August 27 2021
End Date
June 11 2024
Last Update
September 10 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kentucky/Markey Cancer Center
Lexington, Kentucky, United States, 40536
2
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210
3
University of Virginia
Charlottesville, Virginia, United States, 22908
4
West Virginia University
Morgantown, West Virginia, United States, 26506